Trade JnJ ^JNJ

Top Medical Stocks To Follow Today - May 30th - Stock Observer

How to Recession-Proof Your Retirement Income Before Summer 2026

The Two Bucket Income Portfolio That Pays $5,000 a Month Plus a Cash Reserve to Survive 2008 Style Drawdowns

Johnson & Johnson $JNJ Shares Sold by WASHINGTON TRUST Co

Catalyst Capital Advisors LLC Has $1.48 Million Position in Johnson & Johnson $JNJ - Stock Observer

Norges Bank Purchases Shares of 33,459,884 Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (JNJ) Shares Fall 2.4% -- What GF Score of 87

Johnson & Johnson On Pace for Largest Percent Decrease Since May 2025 - Data Talk | Morningstar

Johnson & Johnson (NYSE:JNJ) Shares Down 2.4% - Time to Sell? - Stock Observer

RYBREVANT® plus LAZCLUZE® demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer | INN

New TECVAYLI®▼ (teclistamab) data demonstrate superior progression-free and overall survival versus standard of care as early as first relapse in multiple myeloma

New TECVAYLI® (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma | Morningstar

J&J CEO Joaquin Duato: It's our mission to become the number 1 company in oncology by 2030

Watch CNBC's full interview with Johnson & Johnson Chairman and CEO Joaquin Duato

Savant Capital LLC Has $42.48 Million Position in Johnson & Johnson $JNJ

National Pension Service Purchases 63,957 Shares of Johnson & Johnson $JNJ

Fideuram Asset Management Ireland dac Takes $14.36 Million Position in Johnson & Johnson $JNJ

Houlihan Financial Resource Group Ltd. Buys 4,199 Shares of Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson $JNJ Stock Holdings Boosted by Jupiter Asset Management Ltd. - Stock Observer

Inspire Trust Co. N.A. Decreases Stock Holdings in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (JNJ) Receives FDA Approval for TREMFYA Treatment

Johnson And Johnson MedTech Moves And What They Could Mean For Investors

J&J says FDA approves Tremfya label expansion

FDA approves label expansion, cementing TREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage

3 Dividend Kings to Buy Now to Replace the Social Security Income You're About to Lose

Is Johnson & Johnson Stock Outperforming the Dow?

Johnson & Johnson $JNJ Shares Bought by Geode Capital Management LLC - Stock Observer

Redmond Asset Management LLC Sells 19,168 Shares of Johnson & Johnson $JNJ

Huntington National Bank Sells 6,259 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Holdings Boosted by Smith Chas P & Associates PA Cpas

Johnson & Johnson $JNJ Shares Bought by Smith Chas P & Associates PA Cpas - Stock Observer

Texas Capital Bank Wealth Management Services Inc Increases Stake in Johnson & Johnson $JNJ - Stock Observer

Geode Capital Management LLC Increases Position in Johnson & Johnson $JNJ

Godfrey Financial Associates Inc. Takes $940,000 Position in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson $JNJ Shares Sold by AlphaQuest LLC

Johnson & Johnson at Bernstein Strategic Decisions Conference Transcript

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results | Morningstar

Is It Too Late To Consider Johnson & Johnson (JNJ) After Its Strong Share Price Run? - Simply Wall St News

GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. - AOL

Johnson & Johnson $JNJ Shares Acquired by King Luther Capital Management Corp - Zolmax

M3 Wealth Management LLC Makes New Investment in Johnson & Johnson $JNJ - Zolmax

Best Healthcare Stocks To Consider - May 27th - Daily Political

M3 Wealth Management LLC Purchases New Stake in Johnson & Johnson $JNJ

Integrity Alliance LLC. Raises Stock Holdings in Johnson & Johnson $JNJ

Expressive Wealth LLC Takes Position in Johnson & Johnson $JNJ

Ghe LLC Invests $2.37 Million in Johnson & Johnson $JNJ

Roundview Capital LLC Increases Stake in Johnson & Johnson $JNJ - Stock Observer

Ghe LLC Takes $2.37 Million Position in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (NYSE:JNJ) Receives Average Rating of "Moderate Buy" from Analysts

2,501 Shares in Johnson & Johnson $JNJ Acquired by TrustBank - Daily Political

Johnson & Johnson (NYSE:JNJ) Shares Down 1.7% - Here's Why

Johnson & Johnson (JNJ) Expands Joint Surgery Capabilities with Gemtrack Acquisition

MIA GOP Congressman Still Managed To Find Time To Trade Stocks When He Was Nowhere To Be Seen

Johnson & Johnson (NYSE:JNJ) Shares Down 1.7% - What's Next? - Daily Political

Inflation Adjusted Dividend Income: How to Replace $80,000 in Today's Dollars 20 Years From Now

Here's the defensive stock-market trade that works no matter where bond yields end up | Morningstar

What Leads Companies to Betray Their Own Principles

DePuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across its Joint Reconstruction Portfolio | Morningstar

Best Medical Stocks To Watch Today - May 26th - Daily Political

Johnson & Johnson $JNJ Shares Sold by Tandem Investment Advisors Inc.

Cooke & Bieler LP Has $120.76 Million Stake in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Purchased by Allstate Corp

A Look At Johnson & Johnson (JNJ) Valuation As Investor Interest Builds Around Recent Performance Metrics - Simply Wall St News

Johnson And Johnson Innovation Hub Deal And What It Means For Valuation

Johnson & Johnson (JNJ) Forecast: Elliott Wave Signals Rally Toward $259+ - Forex Market Analysis - ForexCycle.com

Morningstar Investment Management LLC Sells 58,623 Shares of Johnson & Johnson $JNJ - Zolmax

Two Paths to Growth: Johnson & Johnson vs AbbVie - AOL

Johnson & Johnson $JNJ Shares Sold by Hantz Financial Services Inc.

Johnson & Johnson $JNJ Shares Bought by Main Street Research LLC - Daily Political

Genus Capital Management Inc. Increases Stake in Johnson & Johnson $JNJ

HBK Sorce Advisory LLC Sells 3,162 Shares of Johnson & Johnson $JNJ - Stock Observer

Hantz Financial Services Inc. Reduces Stock Holdings in Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson $JNJ is Sectoral Asset Management Inc.'s 7th Largest Position - Daily Political

New Age Alpha Advisors LLC Raises Stake in Johnson & Johnson $JNJ - Daily Political

Churchill Financial Advisors LLC Takes $706,000 Position in Johnson & Johnson $JNJ - Daily Political

Philadelphia Scientist Roohid Parast Advances IBD Research at Johnson & Johnson -- Roohid Parast Science & Fitness | PRLog

Healthcare Stocks To Watch Today - May 24th - Zolmax

Pathfinder Wealth Consulting Inc. Takes Position in Johnson & Johnson $JNJ

Legato Capital Management LLC Sells 9,548 Shares of Johnson & Johnson $JNJ

Legato Capital Management LLC Cuts Position in Johnson & Johnson $JNJ - Stock Observer

First National Trust Co Has $27.05 Million Holdings in Johnson & Johnson $JNJ - Stock Observer

Did New Talc Verdict and MedTech Launch Just Shift Johnson & Johnson's (JNJ) Investment Narrative? - Simply Wall St News

Johnson & Johnson (JNJ) Announces Positive Clinical Study Results for OTTAVA Robotic Surgical System

Guinness Asset Management LTD Decreases Position in Johnson & Johnson $JNJ

Americana Partners LLC Grows Stock Position in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Sold by Kingdom Financial Group LLC. - Stock Observer

Vanguard's VIG Quietly Returned 247% While Investors Chased Higher Yields

ImmunityBio's ANKTIVA Shows Cost-Effectiveness Over TAR-200 in Bladder Cancer Treatment

Johnson & Johnson (NYSE:JNJ) Shares Up 1.3% - Here's What Happened - Daily Political

The Dividend Stocks That Can Replace a $65,000 Income and What They'll Cost You

Why Johnson & Johnson (JNJ) Still Fits a Defensive Growth Case

Johnson And Johnson MedTech Moves And Innovation Hub Tie In Shape Outlook

Meiji Yasuda Asset Management Co Ltd. Reduces Holdings in Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson (NYSE:JNJ) Trading Up 1% - Should You Buy?

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Week ahead: US earnings season kicks off, ECB hold expected

Europe Tries to Ride on US Coat-tails

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk